Genetically altering the thermodynamics and kinetics of hepatitis B virus capsid assembly has profound effects on virus replication in cell culture

Journal of Virology

Volumn 87, Issue 6, 2013, Pages 3208-3216

  Tan, Zhenning ^a   Maguire, Megan L ^b   Loeb, Daniel D ^b   Zlotnick, Adam ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROARYLDIHYDROPYRIMIDINE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE SEQUENCE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; KINETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; STRUCTURE ANALYSIS; THERMODYNAMICS; VIRAL GENETICS; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS REPLICATION;

AMINO ACID SUBSTITUTION; CELL LINE; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; KINETICS; MUTATION, MISSENSE; THERMODYNAMICS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84874698351     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03014-12     Document Type: Article

References (44)

1. Colvin HM, Mitchell AE (ed). 2010. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. National Academies Press, Washington, DC.
2. WHO. 2004. WHO position on the use of hepatitis B vaccines. Wkly. Epidemiol. Rec. 28:255-263.
3. Tillmann HL. 2007. Antiviral therapy and resistance with hepatitis B virus infection. World J. Gastroenterol. 13:125-140.
4. Kwon H, Lok AS. 2011. Hepatitis B therapy. Nat. Rev. Gastroenterol. Hepatol. 8:275-284.
5. Ganem D, Prince AM. 2004. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 350:1118-1129.
6. Nassal M. 2008. Hepatitis B viruses: reverse transcription a different way. Virus Res. 134:235-249.
7. Crowther RA, Kiselev NA, Bottcher B, Berriman JA, Borisova GP, Ose V, Pumpens P. 1994. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77:943-950.
8. Kenney JM, von Bonsdorff CH, Nassal M, Fuller SD. 1995. Evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores. Structure 3:1009-1019.
9. Stannard LM, Hodgkiss M. 1979. Morphological irregularities in Dane particle cores. J. Gen. Virol. 45:509-514.
10. Zlotnick A, Cheng N, Conway JF, Booy FP, Steven AC, Stahl SJ, Wingfield PT. 1996. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry 35: 7412-7421.
11. Dhason MS, Wang JC-Y, Hagan MF, Zlotnick A. 2012. Differential assembly of hepatitis B virus core protein on RNA and DNA correlates with the virus lifecycle. Virology 430:20-29.
12. Ceres P, Zlotnick A. 2002. Weak protein-protein interactions are sufficient to drive assembly of hepatitis B virus capsids. Biochemistry 41: 11525-11531.
13. Endres D, Zlotnick A. 2002. Model-based analysis of assembly kinetics for virus capsids or other spherical polymers. Biophys. J. 83:1217-1230.
14. Katen SP, Zlotnick A. 2009. Thermodynamics of virus capsid assembly. Methods Enzymol. 455:395-417.
15. Zlotnick A, Johnson JM, Wingfield PW, Stahl SJ, Endres D. 1999. A theoretical model successfully identifies features of hepatitis B virus capsid assembly. Biochemistry 38:14644-14652.
16. Packianathan C, Katen SP, Dann CE, 3rd, Zlotnick A. 2010. Conformational changes in the hepatitis B virus core protein are consistent with a role for allostery in virus assembly. J. Virol. 84:1607-1615.
17. Chen C, Wang JC-Y, Zlotnick A. 2011. A kinase chaperones hepatitis B virus capsid assembly and captures capsid dynamics. PLoS Pathog. 7:e1002388. doi:10.1371/journal.ppat.1002388.
18. Bourne C, Lee S, Venkataiah B, Lee A, Korba B, Finn MG, Zlotnick A. 2008. Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle. J. Virol. 82:10262-10270.
19. Katen SP, Chirapu SR, Finn MG, Zlotnick A. 2010. Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators. ACS Chem. Biol. 5:1125-1136.
20. Stray SJ, Bourne CR, Punna S, Lewis WG, Finn MG, Zlotnick A. 2005. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly. Proc. Natl. Acad. Sci. U. S. A. 102:8138-8143.
21. Ceres P, Stray SJ, Zlotnick A. 2004. Hepatitis B virus capsid assembly is enhanced by naturally occurring mutation F97L. J. Virol. 78:9538-9543.
22. Yuan TT, Sahu GK, Whitehead WE, Greenberg R, Shih C. 1999. The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J. Virol. 73:5731-5740.
23. Yuan TT, Tai PC, Shih C. 1999. Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen. J. Virol. 73:10122-10128.
24. Forshey BM, von Schwedler U, Sundquist WI, Aiken C. 2002. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76:5667-5677.
25. Bourne C, Finn MG, Zlotnick A. 2006. Global structural changes in hepatitis B capsids induced by the assembly effector HAP1. J. Virol. 80: 11055-11061.
26. Stray SJ, Zlotnick A. 2006. BAY 41-4109 has multiple effects on hepatitis B virus capsid assembly. J. Mol. Recognit. 19:542-548.
27. Deres K, Schroder CH, Paessens A, Goldmann S, Hacker HJ, Weber O, Kramer T, Niewohner U, Pleiss U, Stoltefuss J, Graef E, Koletzki D, Masantschek RN, Reimann A, Jaeger R, Gross R, Beckermann B, Schlemmer KH, Haebich D, Rubsamen-Waigmann H. 2003. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299:893-896.
28. King RW, Ladner SK, Miller TJ, Zaifert K, Perni RB, Conway SC, Otto MJ. 1998. Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (e)beta- L-2=,3=-dideoxy-3=-thiacytidine. Antimicrob. Agents Chemother. 42: 3179-3186.
29. Perni RB, Conway SC, Ladner SK, Zaifert K, Otto MJ, King RW. 2000. Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication. Bioorg. Med. Chem. Lett. 10:2687-2690.
30. Stoltefuss J, Goldmann S, Krämer T, Schlemmer K-H, Niewöhner U, Paessens A, Lottmann S, Deres K, Weber O. 1 October 1999. New dihydropyrimidine derivatives and their corresponding mesomers useful as antiviral agents. WO patent 9954326.
31. Stolting J, Stoltefuss J, Goldmann S, Kramer T, Schlemmer K-H, Niewohner U, Paessens A, Graef E, Lottmann S, Deres K, Weber O. 2000. Preparation of 4-aryl-2-pyridinyl-1,4-dihydropyrimidine-5- carboxylates for treatment of hepatitis B infection. WO patent 2000- EP2327; 2000058302.
32. Hacker HJ, Deres K, Mildenberger M, Schroder CH. 2003. Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion. Biochem. Pharmacol. 66: 2273-2279.
33. Zlotnick A, Ceres P, Singh S, Johnson JM. 2002. A small molecule inhibits and misdirects assembly of hepatitis B virus capsids. J. Virol. 76: 4848-4854.
34. Porterfield JZ, Zlotnick A. 2010. A simple and general method for determining the protein and nucleic acid content of viruses by UV absorbance. Virology 407:281-288.
35. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646-650.
36. Abraham TM, Lewellyn EB, Haines KM, Loeb DD. 2008. Characterization of the contribution of spliced RNAs of hepatitis B virus to DNA synthesis in transfected cultures of Huh7 and HepG2 cells. Virology 379: 30-37.
37. Lewellyn EB, Loeb DD. 2011. The arginine clusters of the carboxyterminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication. J. Virol. 85:1298-1309.
38. Maguire ML, Loeb DD. 2010. cis-Acting sequences that contribute to synthesis of minus-strand DNA are not conserved between hepadnaviruses. J. Virol. 84:12824-12831.
39. Bourne CR, Katen SP, Fulz MR, Packianathan C, Zlotnick A. 2009. A mutant hepatitis B virus core protein mimics inhibitors of icosahedral capsid self-assembly. Biochemistry 48:1736-1742.
40. Johnson JM, Tang J, Nyame Y, Willits D, Young MJ, Zlotnick A. 2005. Regulating self-assembly of spherical oligomers. Nano Lett. 5:765-770.
41. Feld JJ, Colledge D, Sozzi V, Edwards R, Littlejohn M, Locarnini SA. 2007. The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging. Antiviral Res. 76:168-177.
42. Lewellyn EB, Loeb DD. 2011. Serine phosphoacceptor sites within the core protein of hepatitis B virus contribute to genome replication pleiotropically. PLoS One 6:e17202. doi:10.1371/journal.pone.0017202.
43. Hilmer JK, Zlotnick A, Bothner B. 2008. Conformational equilibria and rates of localized motion within hepatitis B virus capsids. J. Mol. Biol. 375:581-594.
44. Delaney W, Edwards R, Colledge D, Shaw T, Furman P, Painter G, Locarnini S. 2002. Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro. Antimicrob. Agents Chemother. 46:3057-3060.